← Back to Search

One arm for COVID-19

N/A
Recruiting
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Mild to severe persistent respiratory symptoms
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 week
Awards & highlights

Study Summary

This trial aims to see if using wearable technology can help people with post-COVID-19 syndrome manage their symptoms better. The study will also look at how feasible and effective this approach is, which

Who is the study for?
This trial is for individuals who have had COVID-19 and are experiencing persistent respiratory symptoms for at least 3 months after infection. Participants must have access to home internet to use the wearable biometric technology.Check my eligibility
What is being tested?
The study tests a self-management program using wearable biometric devices to monitor health data in people with long-term respiratory issues after COVID-19. It aims to assess how this approach affects their recovery.See study design
What are the potential side effects?
Since the intervention involves self-management and monitoring through wearable technology, there are no direct medical side effects associated with drugs or invasive procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I experience ongoing mild to severe breathing problems.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 week
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 week for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Dyspnea
Change in fatigue
Change in lung capacity
+4 more
Secondary outcome measures
Patient satisfaction with the study
Symptoms change

Trial Design

1Treatment groups
Experimental Treatment
Group I: One armExperimental Treatment1 Intervention
Self-management group. This pilot-study uses a one-group before-after design.

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor
597 Previous Clinical Trials
199,412 Total Patients Enrolled
7 Trials studying COVID-19
6,889 Patients Enrolled for COVID-19
~5 spots leftby Aug 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top